Back to results
US 2010/0137601 A1Published application
Thiazolylimidazole derivatives an their use as inhibitors of microsomal triglyceride transfer protein
OwnerPhilippe GUEDAT, Olivier Chevreuil +1inventors
InventorsPhilippe GUEDAT, Olivier Chevreuil, Thierry Convard
Life of this patent
Estimating the term…
Abstract
The present invention relates to thiazolylimidazole derivatives of the general formula (I) in which: G represents a bond or a divalent radical chosen from the groups g1, g2 and g3; and R1, R2, R3, R4, R5, R6, Y and Z are as defined in the description. Application of the compounds of the formula (I) to the treatment of hypertriglyceridaemia, hypercholesterolaemia and dyslipidaemia.
Claims17
A process for the preparation of a compound of formula (I):
- in which:
- G represents a bond or a divalent radical chosen from the groups g1, g2 and g3 below:
- R1 is chosen from hydrogen and an alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, alkylcarbonyl or alkoxycarbonyl radical;
- R2 and R3, which may be identical or different, are chosen, independently of each other, from a hydrogen atom, an alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl or heteroaryl radical and a radical —NRR′;
- R4, R5 and R6, which may be identical or different, are chosen, independently of each other, from a hydrogen atom and an alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl or heteroaryl radical;
- R and R′, which may be identical or different, represent, independently of each other, a hydrogen atom or a radical chosen from alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl and heteroaryl;
- or together form, with the nitrogen atom that bears them, a heterocycle, or together form the double bond of an alken-1-yl radical;
- Y represents an oxygen or sulfur atom;
- and
- Z represents —NH— or an oxygen atom;
- comprising reacting a compound of the formula (II):
- in which T represents a labile protecting group, with ethyl R3-bromopyruvate, in a polar solvent, in the presence of an excess of base, at a suitable temperature, for a period ranging from 1 to 40 hours,
- so as to form a thiazolyl ring and produce a compound of formula (III):
- saponifying the compound of the formula (III) with an alkali metal or alkaline-earth metal hydroxide base, in polar medium, at room temperature, for a period of 1 to 12 hours, so as to form a salt of formula (IV):
- in which M+ represents the alkali metal or alkaline-earth metal cation derived from the base that is used for the saponification reaction,
- hydrolyzing the compound of formula (IV) to a compound of formula (V):
- converting the compound of formula (V) to a corresponding amide of formula (VI):
- via the action of an amine of formula (VIa):
- in the presence of a base, and a catalyst, in a polar aprotic solvent, at room temperature, for 1 to 50 hours,
- deprotecting of the amine function of the piperidine ring of VI, via the action of an organic or mineral acid, in dichloromethane or dioxane medium, at room temperature, for a few minutes to several hours, to give a compound of formula (VII):
- subjecting said compound VII to the action of:
- in which X represents a halogen atom,
- in the presence of a base, and a catalyst, in a polar aprotic solvent, at room temperature, for 1 to 50 hours,
- to give a compound of the formula (VIII):
- and subjecting VIII to a cyclization reaction to form an imidazole ring, in the presence of a cyclizing agent, acting as a solvent, at a suitable temperature,
- to give a compound of the formula (I).
23 more elements
(canceled)
(canceled)
(canceled)
Dependencies are inferred from the claim text.